Hepatocyte growth factor disrupts tight junctions in human breast cancer cells
暂无分享,去创建一个
G. Watkins | R. Mansel | W. Jiang | T. Martin | W. Jiang
[1] R. Mansel,et al. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4 , 2000, Breast Cancer Research and Treatment.
[2] T. Nakamura,et al. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. , 2003, Carcinogenesis.
[3] P. Argani,et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast , 2003, Oncogene.
[4] R. Mansel,et al. Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells , 2002, Journal of cellular physiology.
[5] E. Barrón,et al. Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor. , 2002, Investigative ophthalmology & visual science.
[6] J. Garcia,et al. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase‐3β , 2002 .
[7] C. Roussakis,et al. Effect of four genes (ALDH1, NRF1, JAM and KBL) on proliferation arrest in a non-small cell bronchopulmonary cancer line. , 2002, Anticancer research.
[8] G. Firestone,et al. Transforming growth factor-alpha abrogates the glucocorticoid stimulation of tight junction formation and reverses the steroid-induced down-regulation of fascin in rat mammary epithelial tumor cells by a Ras-dependent pathway. , 2002, Experimental cell research.
[9] A. Zernecke,et al. JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes , 2002, Nature Immunology.
[10] M. Itoh,et al. Multi-PDZ Domain Protein 1 (MUPP1) Is Concentrated at Tight Junctions through Its Possible Interaction with Claudin-1 and Junctional Adhesion Molecule* , 2002, The Journal of Biological Chemistry.
[11] F. Liu,et al. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] T. Inai,et al. Formation of tight junction strands by expression of claudin-1 mutants in their ZO-1 binding site in MDCK cells , 2002, Histochemistry and Cell Biology.
[13] F. Luscinskas,et al. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte transmigration under flow. , 2001, The American journal of pathology.
[14] W. Jiang,et al. Tight junctions and their role in cancer metastasis. , 2001, Histology and histopathology.
[15] R. Mansel,et al. A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] G. Baldwin,et al. HGF regulates tight junctions in new nontumorigenic gastric epithelial cell line. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[17] E. Dejana,et al. Homophilic Interaction of Junctional Adhesion Molecule* , 2000, The Journal of Biological Chemistry.
[18] M. Kubbies,et al. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer , 2000, Human Genetics.
[19] S. Walsh,et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. , 2000, Journal of cell science.
[20] D. Paul,et al. Occludin 1B, a variant of the tight junction protein occludin. , 2000, Molecular biology of the cell.
[21] N. Hogg,et al. Identification and characterisation of human Junctional Adhesion Molecule (JAM). , 1999, Molecular immunology.
[22] K. Matsumoto,et al. Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells , 1999, Journal of cellular physiology.
[23] K. Matsumoto,et al. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] S. Tsukita,et al. Endothelial Claudin , 1999, The Journal of cell biology.
[25] T. Kita,et al. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. , 1999, Journal of immunology.
[26] B. Kachar,et al. Redistribution and Phosphorylation of Occludin During Opening and Resealing of Tight Junctions in Cultured Epithelial Cells , 1999, The Journal of Membrane Biology.
[27] S. Tsukita,et al. Occludin and claudins in tight-junction strands: leading or supporting players? , 1999, Trends in cell biology.
[28] J. Anderson,et al. Transmembrane proteins in the tight junction barrier. , 1999, Journal of the American Society of Nephrology : JASN.
[29] K. Fujimoto,et al. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Balda,et al. Occludin and the functions of tight junctions. , 1999, International review of cytology.
[31] M. Arpin,et al. Effect of hepatocyte growth factor on assembly of zonula occludens‐1 protein at the plasma membrane , 1998, Journal of cellular physiology.
[32] Kazushi Fujimoto,et al. Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.
[33] R. Mansel,et al. Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. , 1998, Biochemical and biophysical research communications.
[34] V. Wong. Phosphorylation of occludin correlates with occludin localization and function at the tight junction. , 1997, American journal of physiology. Cell physiology.
[35] M. Saitou,et al. Possible Involvement of Phosphorylation of Occludin in Tight Junction Formation , 1997, The Journal of cell biology.
[36] R. Mrsny,et al. Hepatocyte growth factor stimulates the differentiation of human tracheal epithelia in vitro. , 1997, The American journal of physiology.
[37] B. Gumbiner,et al. A Synthetic Peptide Corresponding to the Extracellular Domain of Occludin Perturbs the Tight Junction Permeability Barrier , 1997, The Journal of cell biology.
[38] M. Itoh,et al. Molecular dissection of tight junctions. , 1996, Cell structure and function.
[39] G. Firestone,et al. Glucocorticoid-induced Functional Polarity of Growth Factor Responsiveness Regulates Tight Junction Dynamics in Transformed Mammary Epithelial Tumor Cells (*) , 1995, The Journal of Biological Chemistry.
[40] E. Rosen,et al. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epi , 1994, The Journal of clinical investigation.
[41] H. Kleinman,et al. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo. , 1993, Symposia of the Society for Experimental Biology.